Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandi, G.
Right arrow Articles by Biasco, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandi, G.
Right arrow Articles by Biasco, G.
Clinical Cancer Research Vol. 12, 1299-1307, February 2006
© 2006 American Association for Cancer Research


Cancer Therapy: Preclinical

Intestinal Microflora and Digestive Toxicity of Irinotecan in Mice

Giovanni Brandi1, Jean Dabard4, Pierre Raibaud4, Monica Di Battista1, Chantal Bridonneau4, Anna Maria Pisi3, Antonio Maria Morselli Labate2, Maria Abbondanza Pantaleo1, Antonello De Vivo1 and Guido Biasco1

Authors' Affiliations: 1 "L.A. Seragnoli" Institute of Haematology and Medical Oncology and 2 Department of Internal Medicine and Gastroenterology, Sant'Orsola-Malpighi Hospital; 3 Department of Science and Agroenvironmental Technologies, University of Bologna, Bologna, Italy; and 4 Unité d'Ecologie et de Physiologie du Système Digestif, Institut National de la Recherche Agronomique, Jouy-en-Josas, France

Requests for reprints: Giovanni Brandi, "L.A. Seragnoli" Institute of Haematology and Medical Oncology, Policlinico Sant'Orsola, via Massarenti 9, 40138 Bologna, Italy. Phone: 39-051-6363838; Fax: 39-051-6364037; E-mail gbrandi{at}med.unibo.it.

Purpose: Delayed diarrhea is the most important side effect of irinotecan. The aim of this study was to investigate the role of intestinal microflora on the induction of systemic and intestinal toxicity and diarrhea, studying germ-free and holoxenic mice i.p. injected with irinotecan.

Experimental Design: To evaluate the lethal dose, starting with 100 mg/kg/4 d, we treated the holoxenic mice with 100, 80, and 60 mg/kg/4 d and germ-free mice with 60, 80, 100, and 150 mg/kg/4 d. We recorded the percentage of dead animals, diarrhea, and the epithelial damage to the jejunum, ileum, cecum, and colon at optical and scanning electron microscopy.

Results: Germ-free mice were more resistant to irinotecan than the holoxenic group. The lethal dose was between 60 and 80 mg of irinotecan for holoxenic mice and ≥150 mg for the germ-free. The intestinal damage score was higher in holoxenic than germ-free mice at 100 mg and equally diffuse in the small and large bowel. The damage in germ-free mice was less severe (8 of 40 samples) prevailing in the ileum. The differences were significant for all sites (jejunum, P < 0.001; ileum, P = 0.012; cecum, P = 0.001; colon, P < 0.001). No damage was found in germ-free mice at 60 mg. Diarrhea was present in all 100 and 80 mg holoxenic mice and in 19 of 20 cases at 60 mg whereas it was absent in 60 mg or sporadic in 80 and 100 mg germ-free mice.

Conclusions: The intestinal microflora plays a key role in the intestinal toxicity of irinotecan.




This article has been cited by other articles:


Home page
J Oncol Pharm PractHome page
G. Richardson and R. Dobish
Chemotherapy induced diarrhea
Journal of Oncology Pharmacy Practice, December 1, 2007; 13(4): 181 - 198.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.